日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

An IgE antibody targeting HER2 identified by clonal selection restricts breast cancer growth via immune-stimulating activities

通过克隆选择鉴定的针对 HER2 的 IgE 抗体通过免疫刺激活动限制乳腺癌的生长

Lais C G F Palhares #, Melanie Grandits #, Katie Stoker, Jitesh Chauhan, Heng Sheng Sow, Gilbert O Fruhwirth, Sophia Tsoka, James Birtley, Leanne Partington, Tim Wilson, Elizabeth Hardaker, Sophia N Karagiannis, Heather J Bax, Kevin FitzGerald

Efficacy and pharmacodynamic effect of anti-CD73 and anti-PD-L1 monoclonal antibodies in combination with cytotoxic therapy: observations from mouse tumor models

抗 CD73 和抗 PD-L1 单克隆抗体联合细胞毒疗法的疗效和药效学作用:来自小鼠肿瘤模型的观察

Brajesh P Kaistha, Gozde Kar, Andreas Dannhorn, Amanda Watkins, Grace Opoku-Ansah, Kristina Ilieva, Stefanie Mullins, Judith Anderton, Elena Galvani, Fabien Garcon, Jean-Martin Lapointe, Lee Brown, James Hair, Tim Slidel, Nadia Luheshi, Kelli Ryan, Elizabeth Hardaker, Simon Dovedi, Rakesh Kumar, Rob

Optimization of an Imidazo[1,2- a]pyridine Series to Afford Highly Selective Type I1/2 Dual Mer/Axl Kinase Inhibitors with In Vivo Efficacy

优化咪唑并[1,2- a]吡啶系列以获得具有体内功效的高选择性 I1/2 型双 Mer/Axl 激酶抑制剂

William McCoull, Scott Boyd, Martin R Brown, Muireann Coen, Olga Collingwood, Nichola L Davies, Ann Doherty, Gary Fairley, Kristin Goldberg, Elizabeth Hardaker, Guang He, Edward J Hennessy, Philip Hopcroft, George Hodgson, Anne Jackson, Xiefeng Jiang, Ankur Karmokar, Anne-Laure Lainé, Nicola Lindsay

Development of an ObLiGaRe Doxycycline Inducible Cas9 system for pre-clinical cancer drug discovery

开发 ObLiGaRe 强力霉素诱导 Cas9 系统用于临床前癌症药物研发

Anders Lundin #, Michelle J Porritt #, Himjyot Jaiswal, Frank Seeliger, Camilla Johansson, Abdel Wahad Bidar, Lukas Badertscher, Sandra Wimberger, Emma J Davies, Elizabeth Hardaker, Carla P Martins, Emily James, Therese Admyre, Amir Taheri-Ghahfarokhi, Jenna Bradley, Anna Schantz, Babak Alaeimahabad

PI3Kα/δ inhibition promotes anti-tumor immunity through direct enhancement of effector CD8+ T-cell activity

PI3Kα/δ 抑制可通过直接增强效应 CD8+ T 细胞活性来促进抗肿瘤免疫

Larissa S Carnevalli, Charles Sinclair, Molly A Taylor, Pablo Morentin Gutierrez, Sophie Langdon, Anna M L Coenen-Stass, Lorraine Mooney, Adina Hughes, Laura Jarvis, Anna Staniszewska, Claire Crafter, Ben Sidders, Elizabeth Hardaker, Kevin Hudson, Simon T Barry

Characterisation of lung macrophage subpopulations in COPD patients and controls

慢性阻塞性肺疾病患者和对照组肺巨噬细胞亚群的特征

Jennifer A Dewhurst, Simon Lea, Elizabeth Hardaker, Josiah V Dungwa, Arjun K Ravi, Dave Singh